Comparison of Diagnostic Methods for Pancreatic Insufficiency in Infants With Cystic Fibrosis
- 1 February 2013
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 56 (2) , 178-181
Abstract
The objective of the present study is to compare daily weight gain and laboratory analysis (72-hour fecal fat and steatocrit) with fecal elastase-1 (EL-1) when diagnosing pancreatic insufficiency (PI) in infants with cystic fibrosis (CF). A total of 39 infants with CF, diagnosed consecutively by newborn screening at 2 referral centers, were included in the study. Daily weight gain and results of laboratory analysis of stool samples were compared using the κ coefficient and the receiver operator characteristic (ROC) curve. Using the criterion of low daily weight gain, the frequency of PI was 92.3%; using the 72-hour fecal fat, steatocrit, and fecal EL-1 tests, the frequency was 42.3%, 86.2%, and 84.6%, respectively. EL-1 was used as the reference test. It was observed that the criteria of low daily weight gain (<50th percentile) and abnormal steatocrit, used together, showed the highest sensitivity (91.3%) and specificity (83.3%) for the diagnosis of PI. When fecal EL-1 analysis is not immediately available, low daily weight gain associated with abnormal steatocrit can be adopted as a criterion for initiating pancreatic enzyme replacement therapy in infants with CF; however, EL-1 testing should be performed later for confirmation of PI.Keywords
This publication has 24 references indexed in Scilit:
- Comparison of Monoclonal and Polyclonal ELISAs for Fecal Elastase in Patients With Cystic Fibrosis and Pancreatic InsufficiencyJournal of Pediatric Gastroenterology and Nutrition, 2007
- Función pancreática exocrina en diabetes mellitus: Determinación de elastasa fecalRevista médica de Chile, 2006
- Fecal Elastase-1 Determination: ?Gold Standard? of Indirect Pancreatic Function Tests?Scandinavian Journal of Gastroenterology, 2001
- Comparison of Fecal Elastase-1 Determination with the Secretin-Cholecystokinin Test in Patients with Cystic FibrosisScandinavian Journal of Gastroenterology, 1999
- Using the steatocrit to determine optimal fat content in modular feeds.Archives of Disease in Childhood, 1992
- Reference Values of the Steatocrit and Its Modifications in Diarrheal DiseasesJournal of Pediatric Gastroenterology and Nutrition, 1992
- Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosisThe Journal of Pediatrics, 1992
- Reference data on gains in weight and length during the first two years of lifeThe Journal of Pediatrics, 1991
- The SteatocritJournal of Pediatric Gastroenterology and Nutrition, 1987
- The steatocrit: A simple method for estimating stool fat content in newborn infantsArchives of Disease in Childhood, 1981